Akèy › Kansè Vezik ki pa envazif miskilè › Oregon
Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Oregon
3 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan Oregon.
Tèks ofisyèl etid la (Anglè)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- OHSU Knight Cancer Institute - South Waterfront ( Site 0110), Portland
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Oregon Urology Institute, Springfield
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06919965LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Oregon Health & Science University (OHSU), Portland
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.